CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 106,815,676
- Total 13F shares
- 87,114,680
- Share change
- +1,711,402
- Total reported value
- $2,234,275,240
- Put/Call ratio
- 64%
- Price per share
- $25.64
- Number of holders
- 225
- Value change
- +$46,310,026
- Number of buys
- 114
- Number of sells
- 92
Quarterly Holders Quick Answers
What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 218352102:
Top shareholders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
15,467,633
|
$367,820,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
9,873,663
|
$234,796,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7.3%
|
7,833,871
|
$186,289,000 | — | 30 Jun 2022 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
6.5%
|
6,992,248
|
$166,276,000 | — | 30 Jun 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
5.2%
|
5,537,000
|
$131,670,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
3,499,446
|
$83,217,000 | — | 30 Jun 2022 | |
| Parallel Advisors, LLC |
13F
|
Company |
2.5%
|
2,718,328
|
$64,642,000 | — | 30 Jun 2022 | |
| Novo Holdings A/S |
13F
|
Company |
2.4%
|
2,526,490
|
$60,080,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
2,087,672
|
$49,648,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,629,477
|
$38,748,000 | — | 30 Jun 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
1,611,420
|
$38,319,000 | — | 30 Jun 2022 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.2%
|
1,311,038
|
$31,177,000 | — | 30 Jun 2022 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,220,029
|
$29,012,000 | — | 30 Jun 2022 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
1%
|
1,079,747
|
$25,676,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
997,493
|
$23,720,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.91%
|
966,982
|
$22,996,000 | — | 30 Jun 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.9%
|
960,448
|
$22,839,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.9%
|
960,339
|
$22,838,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
815,192
|
$19,386,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.65%
|
693,825
|
$16,499,159 | — | 30 Jun 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.62%
|
657,667
|
$15,640,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
614,009
|
$14,601,000 | — | 30 Jun 2022 | |
| AJ WEALTH STRATEGIES, LLC |
13F
|
Company |
0.48%
|
509,934
|
$12,126,000 | — | 30 Jun 2022 | |
| S&T BANK/PA |
13F
|
Company |
0.47%
|
498,539
|
$11,855,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.4%
|
425,998
|
$10,130,000 | — | 30 Jun 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
397,326
|
$9,449,000 | — | 30 Jun 2022 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.36%
|
384,231
|
$9,137,000 | — | 30 Jun 2022 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.34%
|
363,303
|
$8,639,000 | — | 30 Jun 2022 | |
| BURNEY CO/ |
13F
|
Company |
0.32%
|
340,488
|
$8,097,000 | — | 30 Jun 2022 | |
| Quantedge Capital Pte Ltd |
13F
|
Company |
0.3%
|
324,412
|
$7,715,000 | — | 30 Jun 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
312,843
|
$7,439,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.29%
|
308,640
|
$7,339,000 | — | 30 Jun 2022 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.28%
|
299,780
|
$7,129,000 | — | 30 Jun 2022 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.26%
|
280,450
|
$6,669,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
275,802
|
$6,559,000 | — | 30 Jun 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.25%
|
266,300
|
$6,333,000 | — | 30 Jun 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.24%
|
254,295
|
$6,047,000 | — | 30 Jun 2022 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.23%
|
249,000
|
$5,922,000 | — | 30 Jun 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.22%
|
237,861
|
$5,656,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.21%
|
228,715
|
$5,439,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.21%
|
224,665
|
$5,343,000 | — | 30 Jun 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.19%
|
207,423
|
$5,260,000 | — | 30 Jun 2022 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.2%
|
218,559
|
$5,197,000 | — | 30 Jun 2022 | |
| TRUSTCORE FINANCIAL SERVICES, LLC |
13F
|
Company |
0.2%
|
208,806
|
$4,965,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.19%
|
205,329
|
$4,883,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
203,667
|
$4,843,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.17%
|
186,873
|
$4,444,000 | — | 30 Jun 2022 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.17%
|
177,018
|
$4,209,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.16%
|
174,873
|
$4,158,000 | — | 30 Jun 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.15%
|
161,522
|
$3,996,000 | — | 30 Jun 2022 |
Institutional Holders of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) as of Q3 2022
As of 30 Sep 2022,
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,114,680 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, INGALLS & SNYDER LLC, FEDERATED HERMES, INC., Parallel Advisors, LLC, STATE STREET CORP, Novo Holdings A/S, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
225
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
214
Q3 2022 holders
225
Holder diff
11
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.